Globe Newswire
Schindellegi, Switzerland – 5 November 2026
Trifork Group AGCompany announcement no. 69/2026
Reporting of transactions made by persons discharging managerial responsibilities
1.Details of the person discharging managerial responsibilities/person closely associateda)NameJørn Larsen2.Reason for the notificationa)Position/statusCEOb)Initial notification/AmendmentInitial notification3.Details of the issuer, emission allowance market participant, auction platform,... (continue reading...)- Completion of key IND-enabling activities represents a major development milestone for LB001
- IND submission remains on track for Q1 2027, followed by initiation of a Phase 1/2 clinical study
- Manufacturing scale-up completed, providing supply for planned clinical studies
LONDON, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Link Biologics (“Link” or “the Company”), the biotech developing first-in-class TSG-6-based therapies that have a unique combination of anti-inflammatory,... (continue reading...)
SHANGHAI, Nov. 05, 2026 (GLOBE NEWSWIRE) -- BioPerfectus introduced the STAX-12A All-in-One Molecular Diagnostic System, a compact benchtop platform developed for sample-to-result molecular testing. The system combines nucleic acid extraction, PCR amplification, multiplex fluorescence detection, and automated result interpretation in one instrument. Through automation, a compact footprint, and customizable assay configurations, STAX-12A supports flexible molecular... (continue reading...)
LONDON, Nov. 05, 2026 (GLOBE NEWSWIRE) -- Axis International Ltd (a UAE-based conglomerate) filed a Memorial on Jurisdiction, Merits and Quantum in an arbitration against the Republic of Guinea before the International Centre for Settlement of Investment Disputes (“ICSID”), an arm of the World Bank, in August 2026. Previously, in December 2025, Axis International requested arbitration of its claim. Guinea responded that it would engage in the arbitration and counter... (continue reading...)
SHANGHAI, Nov. 05, 2026 (GLOBE NEWSWIRE) -- We are advised by Chery Group that journalists and other readers should disregard the news release, “Inside FREELANDER Nightfall, a Brand Evening in Wuhu” issued on November 02, 2026, over GlobeNewswire.
Source: Chery GroupMore Globe Newswire
View Older Stories-
ArrayPatch Completes Oversubscribed €3.2 Million Seed Financing to Advance Next-Generation Microneedle Therapeutics
-
X-SENSE XR0A-iR Smart Radon Detector Now Available on Lowes.com
-
Ethris Reports Positive Topline Phase 2a Data for Nasal mRNA Candidate ETH47 in Asthma Patients Challenged with Rhinovirus
-
The Ride Platform Evolves Its AI-Native Fleet Management Software Platform for the Operator Economy
-
Futu to Report Third Quarter 2026 Financial Results on November 19, 2026
-
Wayvia and Euronics Partner to Connect Brands, Independent Retailers and Shoppers Across 36 Markets
-
Einride and Lorenz Bring Autonomous Fleet to Production Facility in Germany
-
Alethio Therapeutics Raises $90 Million (£67 Million) in Oversubscribed Series A Financing to Advance a New Generation of Therapies for Myeloproliferative Neoplasms
-
Inbank Financial Calendar for 2027
-
Revenue for the nine months ended September 30, 2026
-
Capgemini selected to lead European Commission consortium for AI Safety and Cyber Risk Assessment of advanced AI models
-
Michelin: Disclosure of trading in own shares - November 5th, 2026
-
cBrain expects second-half revenue growth to exceed 20% and upgrades 2026 guidance
-
PRDots Launches in Dubai, Bringing Earned Media, Digital PR, AI Visibility and Link Building Services to Businesses Across the UAE
-
9M 2026: Novonesis delivered 7% organic sales growth, confirming full-year outlook
-
OSB GROUP PLC - Directorate change
-
Eesti Energia to begin preliminary consultations on collective redundancies
-
First Patient Dosed in Phase 1 Trial Evaluating Transgene’s and BioInvent's BT-001 in Patients with Rectal Cancer
-
Equiniti and Leading Banking and Investment Figures Convene to Answer: Can Share Plans Create Lifelong Investors?
-
First Patient Dosed in Phase 1 Trial Evaluating Transgene’s and BioInvent's BT-001 in Patients with Rectal Cancer
-
Eesti Energia Group Unaudited Results for Q3 2026
-
OSB GROUP PLC Announces Cash Tender Offers for its £300,000,000 Fixed Rate Resetting Notes due 7 September 2028 and £400,000,000 Fixed Rate Resetting Notes due 16 January 2030
-
Notice of Q3 2026 Results and Webcast Details
-
OSB GROUP PLC - Trading update for the nine months to 30 September 2026
-
NBPE Announces Transaction in Own Shares
-
T-Therapeutics announces oversubscribed $133 million Series B financing to achieve clinical proof-of-concept for first-in-class TCR bispecific therapies in cancer and autoimmune disease
-
Suominen Corporation’s Interim Report for January 1–September 30, 2026: Continued performance improvement in the third quarter
-
Major Shareholder Announcement
-
Interim report 9M 2026
-
Air France-KLM Q3 2026 Results
-
Interim Report Q3 2026
-
Upgrade of guidance for full year 2026
-
AL Sydbank delivers best quarterly performance and raises its expectations
-
AL Sydbank A/S to revise its expectations upwards as regards profit for 2026
-
New report: Small EU rule change could unlock 9.3 billion euros in investments for circular phosphorus production
-
Satisfactory Q3 result in special circumstances – capital adequacy continued to strengthen
-
ANI Pharmaceuticals Announces Offer to Acquire Egetis Therapeutics, Expanding the Scope and Scale of Its Rare Disease Business
-
Civinity AB continues its note programme: a new tranche of the note issue worth up to EUR 8,000,000, intended to finance the Group’s further expansion
-
Bouygues: Very strong nine-month 2026 Group results, Group full-year COPA now expected to increase slightly
-
Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period
-
EfTEN United Property Fund unaudited financial results for 3rd quarter and 9 months of 2026
-
2026 9 months and III quarter consolidated unaudited interim report
-
Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results and Provides Business Update
-
FTI Consulting Appoints Aurélien Louis to Build on Transactions Capabilities in France
-
Siemens Healthineers to Rebrand In Vitro Diagnostics Business as Olyrian Diagnostics
-
Syensqo third quarter 2026 results
-
IMCD reports EBITA of EUR 425 million (+8%) in the first nine months of 2026
-
ForFarmers N.V.: Trading update Q3 2026
-
ArcelorMittal reports third quarter 2026 results
-
Start of Day Message


